Browsing Tag
Waters Corporation
8 posts
Could Waters’ execution playbook unlock BD’s underperforming diagnostics margins?
Can Waters fix BD’s diagnostic margins post-merger? Learn how service plans, e-commerce, and faster instrument cycles could transform its revenue profile.
What does BD gain from the $4bn cash windfall—and how fast will buybacks follow the spin?
BD’s $4B cash windfall from the Waters merger could reshape its capital strategy. Will buybacks come first, or will growth investments take priority?
Can Waters bring LC-MS into routine diagnostics with BD’s hospital channel access?
Can Waters bring LC-MS to hospitals through its $17.5B BD merger? Find out how this deal could redefine clinical mass spectrometry adoption in diagnostics.
Why did Waters stock fall 12% after the merger announcement—and are investors overreacting to leverage risk?
Waters stock fell 12% after its $17.5B merger news with BD—find out why investors reacted sharply and what could reverse the slide in coming quarters.
BD to merge biosciences and diagnostics unit with Waters in $17.5bn tax-free deal
Waters to merge with BD’s biosciences and diagnostics unit in a $17.5B deal. Explore how the combined firm plans to reshape regulated testing markets.
Waters introduces touch-authenticated HPLC system for end-to-end lab traceability
Waters Corporation launches Alliance iS HPLC Software 2.0 to improve audit readiness, data traceability, and touchscreen security in global pharma labs.
Waters Corporation buys Halo Labs to target hidden impurities in CAR T therapies
Waters Corporation acquires Halo Labs to enhance biologics testing with advanced particle analysis tools for next-gen cell and gene therapies. Learn more.
Waters Corporation to buy light scattering technology firm Wyatt Technology
Waters Corporation will acquire US-based light scattering technology and software solutions provider Wyatt Technology in an all-cash transaction…